| Project/Area Number |
20790639
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Metabolomics
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
HORIKOSHI Momoko The University of Tokyo, 医学部附属病院, 助教 (70422300)
|
|---|
| Research Collaborator |
TAKAMOTO Iseki 東京大学, 医学部付属病院
|
|---|
| Project Period (FY) |
2008 – 2009
|
| Project Status |
Completed (Fiscal Year 2009)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2009: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2008: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 2型糖尿病 / 遺伝子 / インスリン分泌 |
|---|
| Research Abstract |
TCF7L2 gene is widely accepted as a type 2 diabetes (T2D)-associated gene, the mechanism through which, however, is not well known. Thus we investigated its correlation with glucose metabolism by generating a TCF7L2 knock-down mouse with decreased function of TCF7L2 in the pancreatic beta cell. Glucose level of the TCF7L2 knock-down mouse during oral glucose tolerance test (OGTT) was significantly higher compared to the wild type mouse, and its insulin level was lower. Likewise, in human subjects who were homozygous for the T2D risk allele of TCF7L2rs7903146, the glucose levels at 90 min were significantly higher and the insulin levels at 120 min were significantly lower compared to the subjects with no risk allele during 75gOGTT. In conclusion, we demonstrated that the decrease of TCF7L2 function in the pancreatic beta cell will cause glucose intolerance through decreased insulin secretion.
|
